Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients

The New England Journal of Medicine
Erin A BohulaCAMELLIA–TIMI 61 Steering Committee and Investigators

Abstract

Lorcaserin, a selective serotonin 2C receptor agonist that modulates appetite, has proven efficacy for weight management in overweight or obese patients. The cardiovascular safety and efficacy of lorcaserin are undefined. We randomly assigned 12,000 overweight or obese patients with atherosclerotic cardiovascular disease or multiple cardiovascular risk factors to receive either lorcaserin (10 mg twice daily) or placebo. The primary safety outcome of major cardiovascular events (a composite of cardiovascular death, myocardial infarction, or stroke) was assessed at an interim analysis to exclude a noninferiority boundary of 1.4. If noninferiority was met, the primary cardiovascular efficacy outcome (a composite of major cardiovascular events, heart failure, hospitalization for unstable angina, or coronary revascularization [extended major cardiovascular events]) was assessed for superiority at the end of the trial. At 1 year, weight loss of at least 5% had occurred in 1986 of 5135 patients (38.7%) in the lorcaserin group and in 883 of 5083 (17.4%) in the placebo group (odds ratio, 3.01; 95% confidence interval [CI], 2.74 to 3.30; P<0.001). Patients in the lorcaserin group had slightly better values with respect to cardiac risk fa...Continue Reading

References

Aug 28, 1997·The New England Journal of Medicine·H M ConnollyH V Schaff
Aug 24, 2007·The New England Journal of Medicine·Lars SjöströmUNKNOWN Swedish Obese Subjects Study
Feb 7, 2008·The Journal of Pharmacology and Experimental Therapeutics·William J ThomsenDominic Behan
Jul 22, 2010·The New England Journal of Medicine·Steven R SmithUNKNOWN Behavioral Modification and Lorcaserin for Overweight and Obesity Management (BLOOM) Study Group
Sep 8, 2010·The New England Journal of Medicine·W Philip T JamesUNKNOWN SCOUT Investigators
Jul 29, 2011·The Journal of Clinical Endocrinology and Metabolism·Meredith C FidlerUNKNOWN BLOSSOM Clinical Trial Group
Jan 5, 2012·JAMA : the Journal of the American Medical Association·Lars SjöströmLena M S Carlsson
Mar 7, 2012·Circulation·William R HiattAllison B Goldfine
Jan 3, 2013·JAMA : the Journal of the American Medical Association·Katherine M FlegalBarry I Graubard
Jun 26, 2013·The New England Journal of Medicine·Rena R WingSusan Z Yanovski
Nov 14, 2013·Journal of the American Pharmacists Association : JAPhA
Dec 3, 2013·The Journal of Clinical Investigation·Herbert Y Meltzer, Bryan L Roth
May 7, 2014·Journal of Pharmacology & Pharmacotherapeutics·Dick B S BrashierAnjan Khadka
Sep 26, 2014·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·W Timothy GarveyUNKNOWN The Aace Obesity Scientific Committee
Jun 14, 2016·The New England Journal of Medicine·Steven P MarsoUNKNOWN LEADER Trial Investigators
Aug 20, 2016·Journal of the American College of Cardiology·Matthew H VorsangerArthur Z Schwartzbard
Jun 13, 2017·The New England Journal of Medicine·UNKNOWN GBD 2015 Obesity CollaboratorsChristopher J L Murray
Mar 9, 2018·Endocrine Reviews·George A BrayThomas H Inge
Mar 24, 2018·JAMA : the Journal of the American Medical Association·Craig M HalesCynthia L Ogden

❮ Previous
Next ❯

Citations

Jan 3, 2019·The New England Journal of Medicine·Erin A BohulaBenjamin M Scirica
Jan 3, 2019·European Heart Journal·Željko ReinerUlf Landmesser
Dec 28, 2018·Circulation·Benjamin M SciricaUNKNOWN CAMELLIA-TIMI 61 Steering Committee and Investigators
Feb 13, 2019·Current Hypertension Reports·Jordana B Cohen, Kishore M Gadde
Mar 5, 2019·Annals of Internal Medicine·Adam Gilden Tsai, Daniel H Bessesen
Feb 1, 2019·BMJ : British Medical Journal·Zosia Kmietowicz
Apr 5, 2019·Therapeutic Advances in Endocrinology and Metabolism·Gaurav S GulsinGerry P McCann
May 17, 2019·Clinical Medicine : Journal of the Royal College of Physicians of London·Aruchuna RubanJulian Teare
Mar 23, 2019·Endocrine Reviews·Julian M YabutGregory R Steinberg
Jul 30, 2019·Expert Opinion on Drug Discovery·Frances RoseTricia Tan
Feb 1, 2019·BMJ Evidence-based Medicine·Igho J Onakpoya, Jeffrey K Aronson
Nov 7, 2019·Expert Opinion on Pharmacotherapy·Beverly G TchangAlpana P Shukla
Nov 27, 2019·Expert Review of Clinical Pharmacology·Awadhesh Kumar Singh, Ritu Singh
Sep 24, 2019·Journal of Clinical Pharmacy and Therapeutics·Hsiao-Huai KuoLawrence Yu-Min Liu
Dec 10, 2019·Expert Review of Clinical Pharmacology·Awadhesh Kumar Singh, Ritu Singh
Oct 5, 2019·Biomolecules·Ganesh Kumar VeeramachaneniJayakumar Singh Bondili
Dec 4, 2019·Expert Opinion on Pharmacotherapy·Chen-Hsiu LinZhongmin Liu
Apr 14, 2020·Circulation·Suzanne V ArnoldUNKNOWN American Heart Association Council on Lifestyle and Cardiometabolic Health and Council on Clinical Cardiology
Apr 23, 2020·Obesity·Rekha Kumar, Donna Ryan
May 22, 2020·Circulation Research·Sean P HeffronJosé O Alemán
May 15, 2020·The Journal of Clinical Endocrinology and Metabolism·David R SaxonRobert H Eckel
Aug 5, 2020·Expert Opinion on Drug Safety·Ariana M ChaoFrank Silvestry
Sep 8, 2019·Scientific Reports·Andreas LeihererHeinz Drexel
Sep 10, 2020·The New England Journal of Medicine·John SharrettsLisa Yanoff
Sep 8, 2020·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·John P H Wilding, Stephan Jacob
May 11, 2020·Current Obesity Reports·Dimitrios TsilingirisAlexander Kokkinos
Aug 28, 2018·The New England Journal of Medicine·Julie R Ingelfinger, Clifford J Rosen
Jan 8, 2019·Expert Opinion on Pharmacotherapy·Caroline A AndrewLouis J Aronne
Apr 12, 2019·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Rasmus M ChristensenSigne S Torekov
Jun 15, 2019·Metabolomics : Official Journal of the Metabolomic Society·Oscar Daniel Rangel-HuertaAngel Gil
May 9, 2019·Hypertension·Elisabeth A LambertGavin W Lambert
Aug 31, 2019·Diabetology & Metabolic Syndrome·C Cercato, F A Fonseca
Sep 13, 2019·Expert Opinion on Drug Metabolism & Toxicology·Maria Del Mar GutierrezPere Domingo
Jun 12, 2020·Therapeutic Advances in Endocrinology and Metabolism·Kaylee WoodardDaniel S Hsia
Jul 24, 2020·Indian Journal of Endocrinology and Metabolism·Rajeev ChawlaUNKNOWN RSSDI-ESI Consensus Group
Aug 20, 2020·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Charles PirletOlivier F Bertrand
Oct 12, 2018·Nature Reviews. Endocrinology·Carl A Roberts, Jason C G Halford
Feb 23, 2019·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Arshag D Mooradian
Sep 25, 2019·Food & Nutrition Research·Kohei SurugaToshiro Arai

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Antipsychotic-Induced Weight Gain

Antipsychotic-induced weight gain (aiwg) is a common adverse effect of this treatment, particularly with second-generation antipsychotics, and it is a major health problem around the world. Here are the latest discoveries pertaining to AIWG.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Related Papers

The New England Journal of Medicine
Marc A PfefferELIXA Investigators
The New England Journal of Medicine
Rury R HolmanEXSCEL Study Group
The New England Journal of Medicine
Marc P BonacaPEGASUS-TIMI 54 Steering Committee and Investigators
The New England Journal of Medicine
John J V McMurrayATMOSPHERE Committees Investigators
© 2022 Meta ULC. All rights reserved